The phrase "after the second study" is correct and usable in written English.
It can be used to refer to a point in time or a sequence of events that follows the completion of a second study.
Example: "The results were significantly different after the second study was conducted."
Alternatives: "following the second study" or "subsequent to the second study".
After the second study visit, blood samples for analysis of immunogenicity were available for 395 participants in each group.
After the second study using this method, in 2005, there was at least one publication per year on the topic, with a peak in publications in 2012.
After the second study stage (n=27), eight patients (30%95%% CI: 14 50%) were progression free at 12 weeks and the median PFS was 2.3 months (95% CI: 1.7 2.9 months).
After the second study stage (n=35 assessable patients), 8 PR (23%95%% CI 12 39) and 15 SD (43% 95% CI 28 59) were registered, for an overall disease control rate of 66%9595% CI 49 79).
Individual values of BCVA at baseline, week 16 (end of the first study treatment), and week 32 (final evaluation after the second study treatment) are shown in Table 1.
After assessment, the second study recruiter will give their opinion as to whether they would recommend oral or intravenous antibiotic therapy for the patient.
Overall, the level of agreement for all cases was moderate ([kappa]=0.44), and the level of agreement did not change significantly after evaluation of the second study set.
In the first study, 5,156 individuals were followed up two years after their initial interview, while the second study followed 5,288 participants.
The main analyses reported here are based on data collected during and immediately after the first study centre visit.
However, after the first study published in 2005 three other groups have dismissed the polymorphism described in the first paper as a causal mutation.
Reagents and cytometers were characterized and calibrated respectively, after the first study, which resulted in some experimental differences between the two studies preventing the merger of raw data.
